I.-M. von Broen

Melphalan and Prednisone (MP) versus Vincristine, BCNU, Adriamycin, Melphalan and Dexamethasone (VBAM Dex) Induction Chemotherapy and Interferon Maintenance Treatment in Multiple Myeloma

D. Peest, H. Deicher, R. Coldewey et al. · Onkologie · 2009 · 28 citations

Medicine, Oncology, Pharmacology +10

Clinical and pharmacologic phase I study of Cemadotin–HCl (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer

K. Mross, Wolfgang E. Berdel, H.H. Fiebig et al. · Annals of Oncology · 1998 · 23 citations

Medicine, Pharmacokinetics, Pharmacology +13

Phase I Clinical and Pharmacokinetic Study of LU103793 (Cemadotin Hydrochloride) as an Intravenous Bolus Injection in Patients with Metastatic Solid Tumors

K. Mross, Katrina Herbst, W.E. Berdel et al. · Onkologie · 2009 · 16 citations

Pharmacy, Oncology, Pharmacology +17

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours

Ahmad Awada, R. Thödtmann, Martine Piccart et al. · European Journal of Cancer · 2003 · 15 citations

Medicine, Oncology, Pharmacokinetics +14